SCHEMBL23049641

SCHEMBL23049641

CC(=O)N1CCC(N)(C(=O)O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 4/20 0.43
CYP1A2 P05177 4/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALDH1A1 P00352 4/20 0.42
CYP2C19 P33261 3/20 0.42
MAPK1 P28482 3/20 0.42
CYP2C9 P11712 4/20 0.40
CYP2D6 P10635 4/20 0.40
CYP3A4 P08684 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HSD17B10 Q99714 3/20 0.39
HPGD P15428 2/20 0.39
ALOX12 P18054 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HIF1A Q16665 1/20 0.38
NSD2 O96028 1/20 0.38
TSHR P16473 1/20 0.38
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16887675 0.84 CYP1A2 (0.44) USP2CYP1A2TDP1ALDH1A1CYP2C19
SCHEMBL6293711 0.82 NSD2 (0.41) CYP1A2TDP1ALDH1A1CYP2C19CYP2C9
SCHEMBL2716357 0.80 NSD2 (0.39) CYP1A2TDP1ALDH1A1CYP2C19CYP2C9
SCHEMBL16886311 0.78 MEN1 (0.39) USP2CYP1A2TDP1ALDH1A1CYP2C19
SCHEMBL16887537 0.78 MEN1 (0.39) USP2CYP1A2TDP1ALDH1A1CYP2C19
SCHEMBL16365925 0.77 CYP1A2 (0.46) USP2CYP1A2TDP1ALDH1A1CYP2C19
SCHEMBL584005 0.77 CYP1A2 (0.46) USP2CYP1A2TDP1ALDH1A1CYP2C19
SCHEMBL26812142 0.77 CYP1A2 (0.46) USP2CYP1A2TDP1ALDH1A1CYP2C19
SCHEMBL1527385 0.77 NSD2 (0.41) CYP1A2TDP1ALDH1A1CYP2C19CYP2C9
SCHEMBL180284 0.77 F2 (0.43) CYP1A2TDP1ALDH1A1CYP2C19MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596064-B1 TOSYLACETATE BASED COMPOUNDS AND DERIVATIVES THEREOF AS PHGDH INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2021-03-03 EP disclosed